Matt Meyerson headshot

Matt Meyerson

Charles A. Dana Chair in Human Cancer Genetics, Dana-Farber Cancer Institute
Professor of Genetics and Medicine, Harvard Medical School
Director, Center for Cancer Genomics, Dana-Farber Cancer Institute
Dana Farber Cancer Institute
617-632-4377
Meyerson Lab
"Lineage addiction" in human cancer: lessons from integrated genomics.
Authors: Authors: Garraway LA, Weir BA, Zhao X, Widlund H, Beroukhim R, Berger A, Rimm D, Rubin MA, Fisher DE, Meyerson ML, Sellers WR.
Cold Spring Harb Symp Quant Biol
View full abstract on Pubmed
Detection of oncogenic mutations in the EGFR gene in lung adenocarcinoma with differential sensitivity to EGFR tyrosine kinase inhibitors.
Authors: Authors: Thomas RK, Greulich H, Yuza Y, Lee JC, Tengs T, Feng W, Chen TH, Nickerson E, Simons J, Egholm M, Rothberg JM, Sellers WR, Meyerson ML.
Cold Spring Harb Symp Quant Biol
View full abstract on Pubmed
Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.
Authors: Authors: Bentires-Alj M, Paez JG, David FS, Keilhack H, Halmos B, Naoki K, Maris JM, Richardson A, Bardelli A, Sugarbaker DJ, Richards WG, Du J, Girard L, Minna JD, Loh ML, Fisher DE, Velculescu VE, Vogelstein B, Meyerson M, Sellers WR, Neel BG.
Cancer Res
View full abstract on Pubmed
Somatic alterations in the human cancer genome.
Authors: Authors: Weir B, Zhao X, Meyerson M.
Cancer Cell
View full abstract on Pubmed
Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255.
Authors: Authors: Tracy S, Mukohara T, Hansen M, Meyerson M, Johnson BE, Jänne PA.
Cancer Res
View full abstract on Pubmed
Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML.
Authors: Authors: Jiang J, Paez JG, Lee JC, Bo R, Stone RM, DeAngelo DJ, Galinsky I, Wolpin BM, Jonasova A, Herman P, Fox EA, Boggon TJ, Eck MJ, Weisberg E, Griffin JD, Gilliland DG, Meyerson M, Sellers WR.
Blood
View full abstract on Pubmed
Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types.
Authors: Authors: Krop I, Player A, Tablante A, Taylor-Parker M, Lahti-Domenici J, Fukuoka J, Batra SK, Papadopoulos N, Richards WG, Sugarbaker DJ, Wright RL, Shim J, Stamey TA, Sellers WR, Loda M, Meyerson M, Hruban R, Jen J, Polyak K.
Mol Cancer Res
View full abstract on Pubmed
Genomic representations using concatenates of Type IIB restriction endonuclease digestion fragments.
Authors: Authors: Tengs T, LaFramboise T, Den RB, Hayes DN, Zhang J, DebRoy S, Gentleman RC, O'Neill K, Birren B, Meyerson M.
Nucleic Acids Res
View full abstract on Pubmed
Assessing prognosis in non-small-cell lung cancer: avenues to a more complete picture?
Authors: Authors: Dubinett SM, Elashoff D, Meyerson M.
J Clin Oncol
View full abstract on Pubmed
EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.
Authors: Authors: Paez JG, Jänne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, Fujii Y, Eck MJ, Sellers WR, Johnson BE, Meyerson M.
Science
View full abstract on Pubmed